Partner with Amivas Ireland Ltd

Developing and providing safe and effective biopharmaceuticals for unmet medical needs of patients is our first priority. Amivas Ireland Ltd as a subsidiary of Amivas Inc (USA) focused on developing sterile injectable drug products for human use. Our extensive experience in sterile injectable manufacture, drug development, regulatory processes, and in-licencing, means that we can navigate the complex process of providing consistent and high standard products to protect patient safety.

Amivas has demonstrated its successful track record by recently registering Artesunate for Injection, used for the treatment of severe malaria, through the Food and Drug Administration (FDA) in the United States. Amivas can consult on a wide range of drug products by providing in depth expertise and services across all aspects of injectable drug development and licensing.

We are interested in connecting with potential partners who want to bring sterile injectable drugs to market in the United States and other jurisdictions.